G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke

BACKGROUND: Granulocyte Colony-Stimulating Factor (G-CSF) has remarkable neuroprotective properties. Due to its proven safety profile, G-CSF is currently used in clinical stroke trials. As neuroprotectants are considered to be more effective in the early phase of cerebral ischemia and during reperfu...

Full description

Saved in:
Bibliographic Details
Main Authors: Kollmar, Rainer, Henninger, Nils, Urbanek, Christian, Schwab, Stefan
Format: Artigo
Language:Inglês
Published: BioMed Central 2010
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868804/
https://ncbi.nlm.nih.gov/pubmed/20388227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2040-7378-2-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items